Sign in
4

Changes in Ownership

FATE THERAPEUTICS INC Filed Acc 0001104659-24-131794

Director bought 397,964 shares at $1.68 ($668,580)

  • Director sold 341,633 shares at $1.68 ($573,943)
  • Director disposed of 1,084,936 shares (other)
  • Director acquired 1,084,936 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Redmile Group, LLC Director 2024-12-20 Other disposition −1,084,936 $1.68 $1,822,692 11,743,010 I
Redmile Group, LLC Director 2024-12-20 Other acquisition +1,084,936 $1.68 $1,822,692 12,827,946 I
Redmile Group, LLC Director 2024-12-20 Sale −341,633 $1.68 $573,943 12,486,313 I
Redmile Group, LLC Director 2024-12-20 Purchase +397,964 $1.68 $668,580 12,884,277 I
Derivatives
Redmile Group, LLC Director 2024-12-20 Other disposition · Class A Convertible Preferred Stock −116,261 $8.40 $976,592 2,638,825 I
Redmile Group, LLC Director 2024-12-20 Other acquisition · Class A Convertible Preferred Stock +116,261 $8.40 $976,592 2,755,086 I
Redmile Group, LLC Director 2024-12-20 Other disposition · Cash-settled Swaps −56,331 $1.68 $94,636 502,769 I
Open-market purchases · 397,964 sh · avg $1.68 · $668,580
Open-market sales · 341,633 sh · avg $1.68 · $573,943
Loading xslF345X05/tm2431906-1_4seq1.xml…